…ing to a statement issued as part of Merck’s second-quarter earnings statement and reported by Dow Jones (www.nasdaq.com/aspx/stock-market-news-story.aspx?storyid=201107290851dowjonesdjonline000416&title=updatemerck-to-cut-up-to-13,000-jobsreports-2q-net-gain). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…I trial of laquinimod indicate that the drug is no more effective than placebo in reducing relapses, according to a press release issued by Teva Pharmaceuticals (http://hugin.info/1002/R/1535269/468107.pdf) and an August 1st webcast to investors (http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-EventDetails&EventId=4168607). More complete results from the trial are expected to be presented later this year at the European Committee for Treatmen…
…r email address Please enter the email address that you registered the newsletter with Continue…
…U.S. and the deaths of 3,000 civilians, police officers, firefighters and medical personnel. Despite the widespread media coverage of the event, the vital work of volunteer psychiatrists acting as first responders and in researching the aftermath of the tragedy is frequently overlooked. Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…A systematic review concludes that there is insufficient evidence demonstrating significant benefit from non-antiepileptic drugs in trigeminal neuralgia despite their widespread use since the 1970s (Yang et al. Cochrane Database Syst Rev 2011, Jan 19;1:CD004029). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…